Cargando…
Inner ear therapeutics and the war on hearing loss: systemic barriers to success
Despite over 20 years of effort in academic research centers, start-up companies, and established pharmaceutical companies, there are no FDA-approved inner ear therapeutics for treatment of sensorineural hearing loss. There are a number of systemic barriers to creation of this new field of inner ear...
Autores principales: | Jiam, Nicole T., Rauch, Steven D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323325/ https://www.ncbi.nlm.nih.gov/pubmed/37425006 http://dx.doi.org/10.3389/fnins.2023.1169122 |
Ejemplares similares
-
Hearing and sociality: the implications of hearing loss on social life
por: Podury, Archana, et al.
Publicado: (2023) -
Navigating Hereditary Hearing Loss: Pathology of the Inner Ear
por: Nicolson, Teresa
Publicado: (2021) -
Sphingosine 1-phosphate signaling pathway in inner ear biology. New therapeutic strategies for hearing loss?
por: Romero-Guevara, Ricardo, et al.
Publicado: (2015) -
Inner Ear Drug Delivery for Sensorineural Hearing Loss: Current Challenges and Opportunities
por: Liu, Sophie S., et al.
Publicado: (2022) -
Hearing Loss Controlled by Optogenetic Stimulation of Nonexcitable Nonglial Cells in the Cochlea of the Inner Ear
por: Sato, Mitsuo P., et al.
Publicado: (2017)